Boardroom Alpha
Meeting calendar
MPT · Annual meeting · Thursday, May 28, 2026

Medical Properties Trust Inc

9 nominees · 4 ballot items.

Elect nine directors; Ratify PwC as independent auditor; Advisory say-on-pay vote to approve named executive officer compensation; Approve the Second Amended and Restated 2019 Equity Incentive Plan.

Market cap
$2.8B
1Y TSR
+16.8%
Board grade
C-
Record date
Mar 19, 2026
Filing
DEF 14A
Meeting concluded · May 28, 2026

Follow how the vote landed and what changed on Medical Properties Trust Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Election of nine director nominees named in the proxy to serve until the 2027 annual meeting.

  2. 2

    Ratification of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026.

  3. 3

    Advisory Vote to Approve Named Executive Officer Compensation

    ManagementBoard: FOR

    Non-binding, advisory 'say-on-pay' vote to approve the compensation disclosed for named executive officers.

    More detail

    This advisory management proposal asks shareholders to approve, on a non-binding basis, the company’s named executive officers’ compensation as disclosed in the Compensation Discussion and Analysis and accompanying tables. Management frames the ask as a stockholder feedback mechanism—although non-binding, the Compensation Committee and Board commit to consider the vote outcome in future compensation decisions. The proposal arises in the context of prior lower support (58.3% approval in 2025) and ongoing adjustments to pay design (e.g., introduction of Actual Realized Compensation disclosure, reductions to CEO target compensation in 2025) to improve pay-for-performance alignment. Approving this management proposal signals investor acceptance of the current compensation philosophy, including significant performance-based equity components (e.g., TSR-based awards with rigorous hurdles) and specific 2025 changes (reduced CEO target pay, rigorous TSR thresholds, and supplemental metrics). A rejection would convey stockholder dissatisfaction and may prompt further changes to incentive design, disclosure, or governance practices. The Board recommends a FOR vote, citing the program’s pay-for-performance structure, governance safeguards (independent Compensation Committee, clawback policy), and recent shareholder engagement that informed plan design.

  4. 4

    Approval of the Medical Properties Trust, Inc. Second Amended and Restated 2019 Equity Incentive Plan

    ManagementBoard: FOR

    Approve an amendment and restatement of the 2019 Equity Incentive Plan to increase the share reserve by 12,000,000 shares and clarify share recycling rules among other updates.

    More detail

    Management seeks stockholder approval to amend and restate the existing 2019 Equity Incentive Plan to add 12,000,000 shares to the plan reserve and to codify share-counting and recycling rules—specifically disallowing the re-addition to the reserve of shares delivered or withheld to cover the exercise price or taxes on options and SARs, while permitting add-back for forfeitures or shares withheld for tax on full-value awards. The board frames the request as necessary to continue competitive grants to retain and incentivize employees and directors, citing a low 0.45% three-year burn rate, time- and performance-based vesting, and shareholder-friendly terms (no repricing without stockholder approval, no evergreen). The plan changes materially affect dilution dynamics and share accounting. The Board recommends FOR based on its compensation strategy, peer analysis, and governance controls; a negative vote would constrain the company’s ability to grant equity and could affect retention and incentive programs.

Director elections

Nominees on the ballot9

Independent
Tenure on this board
21.0 yrs
Also a director at
Cohen & Co Inc (COHN)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.7.7%45,958,862$213M
2VANGUARD PORTFOLIO MANAGEMENT LLC7.2%43,084,764$199M
3STATE STREET CORP4.3%25,561,209$121M
4VANGUARD CAPITAL MANAGEMENT LLC3.5%20,835,567$96M
5BlackRock, Inc.3.1%18,339,883$85M
6CHARLES SCHWAB INVESTMENT MANAGEMENT INC2.0%11,980,733$55M
7AQR CAPITAL MANAGEMENT LLC1.8%10,866,803$50M
8GEODE CAPITAL MANAGEMENT, LLC1.4%8,611,809$40M
9TWO SIGMA INVESTMENTS, LP1.4%8,400,722$39M
10WILSEY ASSET MANAGEMENT INC1.2%7,348,752$34M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Medical Properties Trust Inc 2026 annual meeting?
Medical Properties Trust Inc (MPT) holds its 2026 annual shareholder meeting on Thursday, May 28, 2026.
What is the record date for the Medical Properties Trust Inc 2026 meeting?
The record date for the Medical Properties Trust Inc 2026 meeting is Thursday, March 19, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Medical Properties Trust Inc's 2026 meeting?
The board is presenting 9 director nominees at the Medical Properties Trust Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Medical Properties Trust Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Medical Properties Trust Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer